Treatment of pheochromocytomas and paragangliomas: genetic approach?

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International journal of endocrine oncology

• Publication date

  2016-11-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.2217/IJE-2016-0016
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma.

  2016cited by this paper
• VON HIPPEL LINDAU SYNDROME AND SURVEILLANCE: A FIVE YEAR FOLLOW UP CASE REPORT.

  2015cited by this paper
• Pheochromocytomas and Paragangliomas: Clinical and Genetic Approaches

  2015cited by this paper
• Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study.

  2014cited by this paper
• Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features

  2014cited by this paper
• Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma.

  2014cited by this paper
• Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.

  2014cited by this paper
• Heterogeneous Genetic Background of the Association of Pheochromocytoma/Paraganglioma and Pituitary Adenoma: Results From a Large Patient Cohort

  2014cited by this paper
• Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

  2014cited by this paper
• The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study

  2014cited by this paper
• Long-term outcomes of surgical treatment for hereditary pheochromocytoma.

  2013cited by this paper
• La neurofibromatose de type 1

  2013cited by this paper
• The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2.

  2013cited by this paper
• One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma.

  2013cited by this paper
• Outcomes of resection of extra-adrenal pheochromocytomas/paragangliomas in the laparoscopic era: a comparison with adrenal pheochromocytoma

  2013cited by this paper
• Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma

  2013cited by this paper
• Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines?

  2013cited by this paper
• An update on the genetics of pheochromocytoma

  2013cited by this paper
• An Update on the Genetics of Paraganglioma, Pheochromocytoma, and Associated Hereditary Syndromes

  2012cited by this paper
• Surgical management of organ-contained unilateral pheochromocytoma: comparative outcomes of laparoscopic and conventional open surgical procedures in a large single-institution series

  2012cited by this paper
• Radionuclide therapy of adrenal tumors

  2012cited by this paper
• External Beam Radiation Therapy (EBRT) for Patients with Malignant Pheochromocytoma and Non-Head and -Neck Paraganglioma: Combination with 131I-MIBG

  2012cited by this paper
• Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE in Individuals with Neck or Mediastinal Paraganglioma (PGL)

  2012cited by this paper
• Partial adrenalectomy minimizes the need for long-term hormone replacement in pediatric patients with pheochromocytoma and von Hippel-Lindau syndrome.

  2012cited by this paper
• Malignant pheochromocytoma: new malignancy criteria

  2012cited by this paper
• Malignant pheochromocytoma: a review.

  2011cited by this paper
• Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma.

  2010cited by this paper
• Radiofrequency ablation of metastatic pheochromocytoma.

  2009cited by this paper
• CLINICS 2012;67(S1):77-84 DOI:10.6061/clinics/2012(Sup01)14 REVIEW Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2

  year unknowncited by this paper

• No citing papers are available for this paper.